Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NAFAMOSTAT Cause Disseminated intravascular coagulation? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Disseminated intravascular coagulation have been filed in association with NAFAMOSTAT. This represents 5.3% of all adverse event reports for NAFAMOSTAT.

5
Reports of Disseminated intravascular coagulation with NAFAMOSTAT
5.3%
of all NAFAMOSTAT reports
3
Deaths
3
Hospitalizations

How Dangerous Is Disseminated intravascular coagulation From NAFAMOSTAT?

Of the 5 reports, 3 (60.0%) resulted in death, 3 (60.0%) required hospitalization, and 4 (80.0%) were considered life-threatening.

Is Disseminated intravascular coagulation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NAFAMOSTAT. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does NAFAMOSTAT Cause?

Off label use (29) Drug ineffective (11) Anaphylactic shock (7) Covid-19 (7) Hypotension (6) Tremor (6) Acute respiratory distress syndrome (5) Diarrhoea (5)

What Other Drugs Cause Disseminated intravascular coagulation?

PREDNISOLONE (362) METHOTREXATE (347) DEXAMETHASONE (323) METHYLPREDNISOLONE (307) NIVOLUMAB (305) CYCLOPHOSPHAMIDE (286) TACROLIMUS (278) PREDNISONE (277) VINCRISTINE (245) OXALIPLATIN (231)

Related Pages

NAFAMOSTAT Full Profile All Disseminated intravascular coagulation Reports All Drugs Causing Disseminated intravascular coagulation NAFAMOSTAT Demographics